Roche Diagnostics Medical Device Company Intelligence Report

Date: June 30, 2012
Pages: 44
Price:
US$ 515.00
Publisher: Espicom Business Intelligence
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: RED3099AF7FEN
Leaflet:

Download PDF Leaflet

Roche Diagnostics Medical Device Company Intelligence Report
Headquartered in Basel, Switzerland, Roche Diagnostics is a division of F. Hoffmann-La Roche Ltd (Roche), the world’s largest biotech company with combined strengths in pharmaceuticals and diagnostics.

Roche Diagnostics is a leading player in in vitro diagnostics (IVD) – tests performed in a laboratory or at the point-of-care (PoC) on blood and other samples from patients – with a 20% share of the global market. It is also a leader in diabetes management.

This profile focuses on Roche Diagnostics’ PoC activities (part of its Professional Diagnostics business), which produces coagulation monitoring systems, professional blood glucose testing and monitoring systems, cardiac marker testing devices, blood gas/electrolyte testing and urinalysis screening products, and its Diabetes Care business, which produces blood glucose monitoring and insulin delivery systems that are used in hospitals, doctors’ offices or patients’ homes for self-testing.

The principal activities of the Professional Diagnostics PoC and Diabetes Care businesses are located in Switzerland, the US, Germany and Austria.

In January 2012, Roche began focusing on expanding its coagulation testing product line in North America beyond physicians’ offices and out-patient clinics, with the development of a full line of coagulation analysers for hospitals and reference labs. To achieve this, the company acquired Verum Diagnostica, a Munich, Germany-based company focused on platelet function testing, which is claimed to be the fastest-growing field in the coagulation diagnostics market. The coagulation analyser product line is expected to be introduced in the US and Canada in 2014, subject to regulatory approval and other requirements. Further attempts to expand into North America were made in 2012 with the failed attempt to acquire Illumina Inc, a San Diego, California-based developer of life-science tools and integrated systems for the analysis of genetic variation and function (see Strategic Focus section). Roche believed this acquisition would have secured its position in the sequencing and microarrays market in North America.

In 2011, Roche Diagnostics was responsible for 22.9% of the Roche Group’s revenue.

This company report provides

Overview Key contact information
  • Introduction to the company and its current activities
  • Summary of its financial performance
  • Who are the company’s major competitors?
  • Key recent events in an “at a glance” format
Financial Review
  • Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
  • Table providing in-depth five-year financial analysis
  • Employee data, including breakdown by company division and geographic location
Strategic Focus
  • Investigates the company’s aims and its areas of focus
Products
  • Core product areas, key brands, product approvals and launches
Research and Development
  • How much has been invested in R&D?
  • Where is the research based?
  • What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
  • Identifying the company’s manufacturing locations
  • Sales and marketing facilities
Agreements
  • With whom has the company reached agreements and what do they involve?
  • Key contracts awarded
Mergers, Acquisitions, and Divestments
Key Corporate Events
OVERVIEW

FINANCIAL REVIEW

First Quarter 2012 Financial Results
2011 Financial results
  Professional Diagnostics
  Diabetes Care
  Molecular Diagnostics
  Applied Science
  Tissue Diagnostics
Five-Year Financial Data
Outlook
Employees

STRATEGIC FOCUS

Operational Excellence Programme
R&D Strategy

PRODUCTS

Recent Key Events
Coagulation Monitoring Systems
Clinical Chemistry/Immunology Testing Solutions
Blood Gas Testing Solutions
Blood Screening (PCR)
Cancer Screening
Cardiac Markers
Urinalysis Testing Solutions
Blood Glucose Testing Solutions
Insulin Pumps

RESEARCH AND DEVELOPMENT

R&D Expenditure
R&D Activities
R&D Facilities
R&D Agreements
  DexCom
  Uppsala BIO
  Merck
  Clovis Oncology
  Rules-Based Medicine
  Genzyme and OSI Pharmaceuticals
  CapitalBio
QIAGEN
  Trials and Studies
  VISION Study
  ATHENA Study
  Accu-Chek 360° View STeP Study

MANUFACTURING AND DISTRIBUTION

AGREEMENTS

Panasonic Healthcare
med fusion
Gen-Probe
Deutsches Krebsforschungszentrum/University Hospital Heidelberg �33
Cedars-Sinai Medical Center
DexCom
Karolinska University Hospital
LabCorp
Response Biomedical
National Health Laboratory Services
Lonza
Eisai
US Department of Defense
Itamar Medical
Fluidigm
Alere
InterComponentWare
Exiquon
Premier
OraSure Technologies
Dade Behring (Siemens)
Iceland Genomics

MERGERS AND ACQUISITIONS

Verum Diagnostica
mtm laboratories
PVT Probenverteiltechnik/PVT Lab Systems
Medical Information Systems Assets
Medingo
Disetronic’s Infusion Systems Business
Amira Medical
AVL Medical

DIVESTITURES

Point-of-care non-clinical drugs-of-abuse testing business
Point-of-care OPTI blood gas analyser product line
OTC pregnancy and ovulation self-testing business

LITIGATION

QIAGEN

KEY CORPORATE EVENTS

LIST OF TABLES

SUMMARY OPERATING RESULTS
Recent Key Events
Roche Group – First Quarter 2012 Sales
Roche Diagnostics - First Quarter 2012 Sales by Business and Geographic Area
Roche Group - Annual Financial Results, 2007-2011
Roche Diagnostics – Annual Sales and Operating Income, 2007-2011
Roche Diagnostics – Annual Sales by Business Area, 2007-2011
Roche Diagnostics – Annual Sales by Geographic Region, 2007-2011
Annual Sales of Professional Diagnostics Products by Geographic Region, 2010-2011
Annual Sales of Diabetes Care Products by Geographic Region, 2010-2011
Annual Sales of Molecular Diagnostics Products by Geographic Region, 2010-2011
Annual Sales of Applied Science Products by Geographic Region, 2010-2011
Annual Sales of Tissue Diagnostics Products by Geographic Region, 2010-2011
Roche Group – Five-Year Financial Summary
Roche Diagnostics - Employees
Roche Diagnostics - Annual R&D Expenditure, 2007-2011
Roche Diagnostics – Major Diabetes Care and Professional Diagnostics Division Manufacturing Facilities
Agreements Summary
Mergers and Acquisitions Summary

LIST OF CHARTS

Roche Diagnostics – Annual Sales and Operating Income, 2007-2011
Roche Diagnostics - Annual Sales by Business Area, 2007-2011
Roche Diagnostics - Annual Sales by Geographic Region, 2007-2011
Roche Diagnostics –Sales by Product Area, 2011
Roche Diagnostics - Key Product Launches Planned for 2012
Roche Diagnostics – Major Product Launches in 2011
Roche Companion Diagnostics on the Market or in Late Development – 2011
Skip to top


Ask Your Question

Roche Diagnostics Medical Device Company Intelligence Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: